S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-0.15%) $77.99
Gas
(0.37%) $2.15
Gold
(0.06%) $2 310.10
Silver
(0.36%) $26.79
Platinum
(0.09%) $966.20
USD/EUR
(-0.31%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.13%) $0.797
USD/RUB
(0.35%) $91.45

Aktualne aktualizacje dla PT Indofarma Tbk [INAF.JK]

Giełda: JKT Sektor: Healthcare Branża: Drug Manufacturers—Specialty & Generic
Ostatnio aktualizowano3 geg. 2024 @ 12:00

0.75% IDR 135.00

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 12:00):

PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory...

Stats
Dzisiejszy wolumen 40 900.00
Średni wolumen 197 939
Kapitalizacja rynkowa 418.40B
EPS IDR0 ( 2024-04-28 )
Następna data zysków ( IDR0 ) 2024-08-01
Last Dividend IDR0 ( N/A )
Next Dividend IDR0 ( N/A )
P/E -0.960
ATR14 IDR0 (0.00%)

PT Indofarma Tbk Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PT Indofarma Tbk Finanse

Annual 2022
Przychody: IDR1 144.11B
Zysk brutto: IDR-110.11B (-9.62 %)
EPS: IDR-138.25
FY 2022
Przychody: IDR1 144.11B
Zysk brutto: IDR-110.11B (-9.62 %)
EPS: IDR-138.25
FY 2021
Przychody: IDR2 901.99B
Zysk brutto: IDR451.65B (15.56 %)
EPS: IDR-13.63
FY 2020
Przychody: IDR1 715.59B
Zysk brutto: IDR400.60B (23.35 %)
EPS: IDR0.0100

Financial Reports:

No articles found.

PT Indofarma Tbk

PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory. It also provides COVID-19 test services, including rapid diagnostic test antigen; reverse transcription polymerase chain reaction, and genose. The company also exports its products. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk operates as a subsidiary of PT. Bio Farma.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej